Luteolin mitigates oxidative stress and multi-organ impairment in a propionic acid-induced rodent model of autism

Background/objectivesOxidative stress, organ impairments, and gastrointestinal abnormalities are the most common systemic dysfunctions that accompanied the neurodevelopmental condition, Autism Spectrum Disorder (ASD). Emerging evidence suggests that increased propionic acid (PPA) levels contribute t...

Full description

Saved in:
Bibliographic Details
Main Authors: Arwa Ishaq Abdulmalik Khayyat, Altaf N. Alabdali, Mona Alonazi, Areej Ali Alzahrani, Eman Al-Shehri, Abir Ben Bacha
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-05-01
Series:Frontiers in Nutrition
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fnut.2025.1583119/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850127284676067328
author Arwa Ishaq Abdulmalik Khayyat
Altaf N. Alabdali
Mona Alonazi
Areej Ali Alzahrani
Eman Al-Shehri
Abir Ben Bacha
author_facet Arwa Ishaq Abdulmalik Khayyat
Altaf N. Alabdali
Mona Alonazi
Areej Ali Alzahrani
Eman Al-Shehri
Abir Ben Bacha
author_sort Arwa Ishaq Abdulmalik Khayyat
collection DOAJ
description Background/objectivesOxidative stress, organ impairments, and gastrointestinal abnormalities are the most common systemic dysfunctions that accompanied the neurodevelopmental condition, Autism Spectrum Disorder (ASD). Emerging evidence suggests that increased propionic acid (PPA) levels contribute to ASD pathophysiology through oxidative stress, neuroinflammation and disruption of the gut-liver-brain axis. Thanks to its strong anti-inflammatory and antioxidant potencies, luteolin, has shown to be promising in alleviating these effects. This study investigated the therapeutic and protective effects of luteolin in a PPA-induced rodent model of ASD by assessing oxidative stress, intestinal permeability, and liver and kidney dysfunction biomarkers.MethodsFifty young male albino rats were divided into five groups: control, PPA-treated, luteolin-treated, therapeutic (PPA followed by luteolin), and protective (luteolin followed by PPA). Oxidative stress markers (GSH, lipid peroxides, GST, SOD, and catalase), serum zonulin, liver enzymes (ALT, AST, ALP) and renal function markers (urea nitrogen, creatinine) were investigated. ROC analysis evaluated the diagnostic potential of these biomarkers, while Spearman correlation analysis explored interrelationships among parameters.ResultsPPA administration significantly reduced antioxidant defenses, including GSH, GST, SOD, and catalase, while increasing lipid peroxidation and inducing hepatic and renal dysfunction, as evidenced by elevated ALT, AST, ALP, urea nitrogen, and creatinine levels, along with increased zonulin levels. Luteolin intervention effectively reversed these alterations by restoring antioxidant capacity, lowering zonulin levels, and improving liver and kidney function. ROC analysis demonstrated high diagnostic accuracy (AUC = 1.000) for oxidative stress and organ dysfunction markers in the PPA-treated group, while luteolin treatment significantly enhanced biomarker sensitivity and specificity. Spearman correlation analysis revealed strong negative correlations between antioxidants and oxidative stress markers (p < 0.001) and positive correlations between zonulin and liver/kidney dysfunction indicators (p < 0.001), further confirming the systemic impact of PPA.ConclusionLuteolin effectively alleviated oxidative stress, restored antioxidant defenses, and enhanced liver, kidney, and intestinal barrier functions in a PPA-induced ASD model. These findings underscored its therapeutic potential as a natural intervention for ASD-related systemic dysfunctions. Further clinical studies are needed to evaluate its translational applicability in ASD management.
format Article
id doaj-art-255cd29a44d54a22a901ea94113fad12
institution OA Journals
issn 2296-861X
language English
publishDate 2025-05-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Nutrition
spelling doaj-art-255cd29a44d54a22a901ea94113fad122025-08-20T02:33:43ZengFrontiers Media S.A.Frontiers in Nutrition2296-861X2025-05-011210.3389/fnut.2025.15831191583119Luteolin mitigates oxidative stress and multi-organ impairment in a propionic acid-induced rodent model of autismArwa Ishaq Abdulmalik KhayyatAltaf N. AlabdaliMona AlonaziAreej Ali AlzahraniEman Al-ShehriAbir Ben BachaBackground/objectivesOxidative stress, organ impairments, and gastrointestinal abnormalities are the most common systemic dysfunctions that accompanied the neurodevelopmental condition, Autism Spectrum Disorder (ASD). Emerging evidence suggests that increased propionic acid (PPA) levels contribute to ASD pathophysiology through oxidative stress, neuroinflammation and disruption of the gut-liver-brain axis. Thanks to its strong anti-inflammatory and antioxidant potencies, luteolin, has shown to be promising in alleviating these effects. This study investigated the therapeutic and protective effects of luteolin in a PPA-induced rodent model of ASD by assessing oxidative stress, intestinal permeability, and liver and kidney dysfunction biomarkers.MethodsFifty young male albino rats were divided into five groups: control, PPA-treated, luteolin-treated, therapeutic (PPA followed by luteolin), and protective (luteolin followed by PPA). Oxidative stress markers (GSH, lipid peroxides, GST, SOD, and catalase), serum zonulin, liver enzymes (ALT, AST, ALP) and renal function markers (urea nitrogen, creatinine) were investigated. ROC analysis evaluated the diagnostic potential of these biomarkers, while Spearman correlation analysis explored interrelationships among parameters.ResultsPPA administration significantly reduced antioxidant defenses, including GSH, GST, SOD, and catalase, while increasing lipid peroxidation and inducing hepatic and renal dysfunction, as evidenced by elevated ALT, AST, ALP, urea nitrogen, and creatinine levels, along with increased zonulin levels. Luteolin intervention effectively reversed these alterations by restoring antioxidant capacity, lowering zonulin levels, and improving liver and kidney function. ROC analysis demonstrated high diagnostic accuracy (AUC = 1.000) for oxidative stress and organ dysfunction markers in the PPA-treated group, while luteolin treatment significantly enhanced biomarker sensitivity and specificity. Spearman correlation analysis revealed strong negative correlations between antioxidants and oxidative stress markers (p < 0.001) and positive correlations between zonulin and liver/kidney dysfunction indicators (p < 0.001), further confirming the systemic impact of PPA.ConclusionLuteolin effectively alleviated oxidative stress, restored antioxidant defenses, and enhanced liver, kidney, and intestinal barrier functions in a PPA-induced ASD model. These findings underscored its therapeutic potential as a natural intervention for ASD-related systemic dysfunctions. Further clinical studies are needed to evaluate its translational applicability in ASD management.https://www.frontiersin.org/articles/10.3389/fnut.2025.1583119/fullautism spectrum disorderluteolinoxidative stressleaky gutliverkidney
spellingShingle Arwa Ishaq Abdulmalik Khayyat
Altaf N. Alabdali
Mona Alonazi
Areej Ali Alzahrani
Eman Al-Shehri
Abir Ben Bacha
Luteolin mitigates oxidative stress and multi-organ impairment in a propionic acid-induced rodent model of autism
Frontiers in Nutrition
autism spectrum disorder
luteolin
oxidative stress
leaky gut
liver
kidney
title Luteolin mitigates oxidative stress and multi-organ impairment in a propionic acid-induced rodent model of autism
title_full Luteolin mitigates oxidative stress and multi-organ impairment in a propionic acid-induced rodent model of autism
title_fullStr Luteolin mitigates oxidative stress and multi-organ impairment in a propionic acid-induced rodent model of autism
title_full_unstemmed Luteolin mitigates oxidative stress and multi-organ impairment in a propionic acid-induced rodent model of autism
title_short Luteolin mitigates oxidative stress and multi-organ impairment in a propionic acid-induced rodent model of autism
title_sort luteolin mitigates oxidative stress and multi organ impairment in a propionic acid induced rodent model of autism
topic autism spectrum disorder
luteolin
oxidative stress
leaky gut
liver
kidney
url https://www.frontiersin.org/articles/10.3389/fnut.2025.1583119/full
work_keys_str_mv AT arwaishaqabdulmalikkhayyat luteolinmitigatesoxidativestressandmultiorganimpairmentinapropionicacidinducedrodentmodelofautism
AT altafnalabdali luteolinmitigatesoxidativestressandmultiorganimpairmentinapropionicacidinducedrodentmodelofautism
AT monaalonazi luteolinmitigatesoxidativestressandmultiorganimpairmentinapropionicacidinducedrodentmodelofautism
AT areejalialzahrani luteolinmitigatesoxidativestressandmultiorganimpairmentinapropionicacidinducedrodentmodelofautism
AT emanalshehri luteolinmitigatesoxidativestressandmultiorganimpairmentinapropionicacidinducedrodentmodelofautism
AT abirbenbacha luteolinmitigatesoxidativestressandmultiorganimpairmentinapropionicacidinducedrodentmodelofautism